Skip to search formSkip to main contentSkip to account menu

Captodiamine

Known as: 2-((p-(Butylthio)-alpha-phenylbenzyl)thio)-N,N-dimethylethylamine, 2-[(4-butylsulfanylphenyl)-phenyl-methyl]sulfanyl-N,N-dimethylethanamine, Captodiame 
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (2)

Captodiamine hydrochlorideN 68

Broader (2)

EthylaminesSulfides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
The role of captodiamine in the withdrawal from long-term benzodiazepine treatment
SUMMARY Background and objectives: Discontinuation of benzodiazepines can be associated with the emergence of a withdrawal… 
1999
1999
Comparative Study of the Effects of Captodiamine and Lorazepam on Car Driving Ability
AbstractObjective: To compare the effects of lorazepam, a benzodiazepine-type anxiolytic agent, with those of captodiamine, a non… 
1963
1963
[PHARMACOLOGICAL PROPERTIES OF SOME CAPTODIAMINE ANALOGUES].
1960
1960
Captodiame in anxiety states in general practice.
1960
1960
Captodiame in anxiety states in general practice.
1960
1960
NEURODERMATOSES AND CAPTODIAME
The drug chosen for trial was p-butylthiodiphenyl-methyl-2-dimethylaminoethyl sulphide hydrochloride, the approved name for which… 
1959
1959
Report on a new drug, captodiamine: a preliminary investigation.
1959
1959
Report on a new drug, captodiamine: a preliminary investigation.
1958
1958
[Mechanism of the potentiating effect of captodiamine on hexobarbital].
1957
1957
[A new tranquilizing drug: captodiamine].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)